Cargando…
In vitro screening of major neurotransmitter systems possibly involved in the mechanism of action of antibodies to S100 protein in released-active form
Experimentally and clinically, it was shown that released-active form of antibodies to S100 protein (RAF of Abs to S100) exerts a wide range of pharmacological activities: anxiolytic, antiasthenic, antiaggressive, stress-protective, antihypoxic, antiischemic, neuroprotective, and nootropic. The purp...
Autores principales: | Gorbunov, Evgeniy A, Ertuzun, Irina A, Kachaeva, Evgeniya V, Tarasov, Sergey A, Epstein, Oleg I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639559/ https://www.ncbi.nlm.nih.gov/pubmed/26604768 http://dx.doi.org/10.2147/NDT.S92456 |
Ejemplares similares
-
Dose–Response Effect of Antibodies to S100 Protein and Cannabinoid Receptor Type 1 in Released-Active Form in the Light–Dark Test in Mice
por: Kardash, Elena V., et al.
Publicado: (2018) -
Subetta Treatment Increases Adiponectin Secretion by Mature Human Adipocytes In Vitro
por: Nicoll, Jim, et al.
Publicado: (2013) -
RETRACTED ARTICLE: Release-Active Dilutions of Diclofenac Enhance Anti-inflammatory Effect of Diclofenac in Carrageenan-Induced Rat Paw Edema Model
por: Sakat, Sachin S., et al.
Publicado: (2013) -
Subetta increases phosphorylation of insulin receptor β-subunit alone and in the presence of insulin
por: Gorbunov, E A, et al.
Publicado: (2015) -
Novel Approach to Activity Evaluation for Release-Active Forms of Anti-Interferon-Gamma Antibodies Based on Enzyme-Linked Immunoassay
por: Gavrilova, Elena S., et al.
Publicado: (2014)